GlaxoSmithkline Pharmaceuticals divests land in Mumbai

31 Aug 2019

GlaxoSmithkline Pharmaceuticals has divested its lands at Thane in Mumbai admeasuring around 2.40 lakh square meters in favour of Oberoi Realty for a total consideration of Rs 889.50 crore. A small portion, admeasuring around 1,410 square meters, is excluded from this sale owing to a stay order passed by the Bombay High Court on October 12, 2017. The company has paid a sum of Rs 337.46 crore towards obtaining all required statutory and regulatory approvals.

GlaxoSmithKline Pharmaceuticals (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines.

Related Glaxosmithkline Pharmaceuticals Ltd. Links:

Glaxosmithkline Phar Share Price

1601.25 0.00 (0.00%) Nov 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 410.05
Lupin 738.25
Dr. Reddys Lab 2734.00
Piramal Enterprises 1758.75
Cadila Healthcare 234.20
View more..
Sensex vs Glaxosmithkline Phar
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463